Researchers have developed a way to use smartphone images of a person’s eyelids to assess blood hemoglobin levels. The ability to perform one of the most common clinical lab tests without a blood draw could help reduce the need for in-person clinic visits, make it easier to monitor patients who are in critical condition, and improve care in low- and middle-income countries where access to testing laboratories is limited.
«Our new mobile health approach paves the way for bedside or remote testing of blood hemoglobin levels for detecting anemia, acute kidney injury and hemorrhages, or for assessing blood disorders such as sickle cell anemia.» said research team leader Young Kim from Purdue University. «The COVID-19 pandemic has greatly increased awareness of the need for expanded mobile health and telemedicine services.»
Kim and colleagues from the University of Indianapolis, Vanderbilt University School of Medicine in the US and Moi University School of Medicine in Kenya report the new approach in Optica, The Optical Society’s journal for high impact research.
The researchers used software to transform the built-in camera of a smartphone into a hyperspectral imager that reliably measures hemoglobin levels (a measure of the oxygen-carrying capacity of blood) without the need for any hardware modifications or accessories. A pilot clinical test with volunteers at the Moi University Teaching and Referral Hospital showed that prediction errors for the smartphone technique were within 5 to 10 percent of those measured with clinical laboratory blood.
Kim’s lab focuses on developing healthcare technologies that are first designed and tested in the resource-limited settings of low- and middle-income countries. These innovations are then applied to important health challenges in developed countries such as the US.
«This new technology could be very useful for detecting anemia, which is characterized by low levels of blood hemoglobin,» said Kim. «This is a major public health problem in developing countries, but can also be caused by cancer and cancer treatments.»
Spectral information from a smartphone
Story Source:
Materials provided by The Optical Society. Note: Content may be edited for style and length.